Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03430700
Title Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer (PROMPT)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.